Hurler syndrome classification: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==Overview== | ||
MPS I is divided into three subtypes based on severity of symptoms. All three types result from an absence of, or insufficient levels of, the enzyme alpha-L-iduronidase. | MPS I is divided into three subtypes based on severity of symptoms. All three types result from an absence of, or insufficient levels of, the enzyme alpha-L-iduronidase. MPS I H or Hurler syndrome is the most severe of the MPS I subtypes. The other two types are MPS I S or [[Scheie syndrome]] and MPS I H-S or [[Hurler-Scheie syndrome]]. | ||
MPS I H or Hurler syndrome is the most severe of the MPS I subtypes. The other two types are MPS I S or [[Scheie syndrome]] and MPS I H-S or [[Hurler-Scheie syndrome]]. | |||
Hurler's Syndrome is often classified as a [[lysosomal storage disease]] and is mechanistically related to Hunter's Syndrome (X-linked recessive). | Hurler's Syndrome is often classified as a [[lysosomal storage disease]] and is mechanistically related to Hunter's Syndrome (X-linked recessive). | ||
| Line 15: | Line 13: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
Revision as of 21:16, 25 February 2013
|
Hurler Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hurler syndrome classification On the Web |
|
American Roentgen Ray Society Images of Hurler syndrome classification |
|
Risk calculators and risk factors for Hurler syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
MPS I is divided into three subtypes based on severity of symptoms. All three types result from an absence of, or insufficient levels of, the enzyme alpha-L-iduronidase. MPS I H or Hurler syndrome is the most severe of the MPS I subtypes. The other two types are MPS I S or Scheie syndrome and MPS I H-S or Hurler-Scheie syndrome.
Hurler's Syndrome is often classified as a lysosomal storage disease and is mechanistically related to Hunter's Syndrome (X-linked recessive).